A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy
- DOI
- 10.1097/dcr.0000000000003987
- Published
- 2025-10-24
- Container
- Diseases of the Colon & Rectum
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/dcr.0000000000003987,
title = {A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy},
author = {Laura M. Fernandez and José Moreira Azevedo and Ines Santiago and Mireia Castillo-Martin and Barbara Cardoso and Carlos T. Carvalho and Richard J. Heald and Amjad Parvaiz},
year = {2025},
journal = {Diseases of the Colon \& Rectum},
doi = {10.1097/dcr.0000000000003987},
url = {https://doi.org/10.1097/dcr.0000000000003987}
}RIS
TY - JOUR TI - A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy AU - Laura M. Fernandez AU - José Moreira Azevedo AU - Ines Santiago AU - Mireia Castillo-Martin AU - Barbara Cardoso AU - Carlos T. Carvalho AU - Richard J. Heald AU - Amjad Parvaiz PY - 2025 JO - Diseases of the Colon & Rectum DO - 10.1097/dcr.0000000000003987 UR - https://doi.org/10.1097/dcr.0000000000003987 ER -
APA
Fernandez, L. M., Azevedo, J. M., Santiago, I., Castillo-Martin, M., Cardoso, B., Carvalho, C. T., Heald, R. J., & Parvaiz, A. (2025). A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy. Diseases of the Colon & Rectum. https://doi.org/10.1097/dcr.0000000000003987
Source records
- crossref · retrieved 2026-09-26T14:19:12.611Z